Cargando…
Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection
BACKGROUND: The basis of the less severe clinical presentation of coronavirus disease 2019 (COVID-19) in children as compared with adults remains incompletely understood. Studies have suggested that a more potent boosting of immunity to endemic common cold coronaviruses (HCoVs) may protect children....
Autores principales: | Tomasi, Lisa, Thiriard, Anais, Heyndrickx, Leo, Georges, Daphnée, Van den Wijngaert, Sigi, Olislagers, Véronique, Sharma, Shilpee, Matagne, André, Ackerman, Margaret E, Ariën, Kevin K, Goetghebuer, Tessa, Marchant, Arnaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709628/ https://www.ncbi.nlm.nih.gov/pubmed/36467295 http://dx.doi.org/10.1093/ofid/ofac554 |
Ejemplares similares
-
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
por: Kemlin, Delphine, et al.
Publicado: (2023) -
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
por: Hederman, Andrew P., et al.
Publicado: (2023) -
Prevalence, Risk Factors, and Serotype Distribution of Group B Streptococcus Colonization in HIV-Infected Pregnant Women Living in Belgium: A Prospective Cohort Study
por: Dauby, Nicolas, et al.
Publicado: (2018) -
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
por: Pannus, Pieter, et al.
Publicado: (2023) -
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19
por: Thiriard, Anaïs, et al.
Publicado: (2023)